Program Faculty

Kristen Watt, BSc Phm, RPh

Pharmacist,

Southampton, ON

Sohal Goyal, MD, CCFP, FCFP

Family Physician

Mississauga, ON

Angel Chu, MD, FRCPC

Infectious Diseases Specialist

Calgary, AB

Alex Carignan, MD, MSc

Medical Microbiologist & Infectious Disease Consultant

Sherbrooke, Quebec

Simon Lessard, Pharm.D, MBA, CRE, CTE, FOPQ

Pharmacist

Saint-Jerôme, QC

Objectives


At the end of the program, participants will be able to:
  • Determine which patients would benefit from an additional dose of COVID-19 vaccine 
  • Individualize treatment for patients with mild to moderate COVID-19 who are at higher risk for severe outcomes
  • Assess and manage patients with post–COVID-19 condition 

Disclosure of Financial Support


This program has received financial support from Pfizer Canada ULC.
This program has received in-kind support from Pfizer Canada ULC. 

Potential for conflict(s) of interest:

  • The faculty members have received honoraria from Pfizer Canada ULC.  
  • Pfizer Canada ULC benefits from the sale of products that will be discussed in this program.

Disclaimers


  • The views expressed in this program are the personal views of the presenter(s) and do not necessarily reflect the views of Pfizer Canada Inc. 
  • This program may contain information about drugs or indications that have not been authorized for marketing in Canada.
  • This program may contain content that is not consistent with the approved Pfizer Canadian Product Monograph.
  • This program includes national guideline recommendations and other health and/or regulatory body recommendations that may differ from the Pfizer Canadian Product Monograph recommendations.
  • In compliance with the Innovative Medicines Canada Code of Ethical Practices, this program is available to Healthcare Professionals only.